Related Experiment Video
Updated: Aug 21, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
[Beta-cell, thyroid and celiac autoimmunity in children with type 1 diabetes]
J A López Medina1, R López-Jurado Romero de la Cruz, A Delgado García
1Servicio de Pediatría, Hospital Universitario Virgen de las Nieves, Granada, Spain. jalopezmedina@eresmas.com
Insights
Children with new-onset type 1 diabetes often have co-existing thyroid and coeliac autoimmunity. Early detection and intervention for these conditions are crucial for managing diabetes complications and improving patient outcomes.
Area of Science:
- Pediatrics
- Endocrinology
- Immunology
Background:
- Type 1 diabetes (T1D) is an autoimmune disease.
- Autoimmune conditions often coexist in individuals with T1D.
- Screening for associated autoimmune diseases is important in pediatric T1D.
Purpose of the Study:
- To assess the prevalence of beta-cell, thyroid, and coeliac autoimmunity in children with recent-onset T1D.
- To identify potential associations between autoimmune markers and clinical characteristics.
Main Methods:
- A cohort of 63 children (aged 2-14 years) with newly diagnosed T1D was studied.
- Antibody testing included GADA, AIA, anti-TPO, anti-TG, TSI, and EmA-IgA.
- Data on patient demographics and thyroid function were collected.
Main Results:
- High prevalence of autoantibodies: GADA (65.1%), AIA (68.3%).
- Thyroid autoimmunity detected in 11.1% (anti-TPO) and 9.5% (anti-TG).
- Coeliac autoimmunity (EmA-IgA) found in 3.1% of patients. Children with thyroid antibodies were older at diagnosis and had higher rates of thyroid dysfunction.
Conclusions:
- Newly diagnosed pediatric T1D patients exhibit a significant prevalence of thyroid and coeliac autoimmunity.
- Routine screening for these autoimmune conditions is recommended.
- Early detection and management can mitigate complications and improve the clinical course of T1D.
Objective:
The aim of this study was to evaluate the presence of beta-cell, thyroid and coeliac autoimmunity in children with recent-onset type 1 diabetes.
Methods:
We studied all children with newly diagnosed type 1 diabetes. Data were analyzed from 63 children aged 2-14 years who were treated in the Department of Pediatrics of the Virgen de las Nieves University Hospital in Granada (Spain) from 1998-2002. Antibodies to glutamic acid decarboxylase-65 (GADA), anti-insulin (AIA), thyroperoxidase (anti-TPO), thyroglobulin (anti-TG), thyroid-stimulating immunoglobulins (TSI) and endomysial antibodies (EmA-IgA) were measured and documented. A total of 55.5 % of these patients were girls and the mean age was 7.9 +/- 3.2 years.
Results:
The prevalence rates were: GADA 65.1 %; AIA 68.3 %; anti-TPO 11.1 %; anti-TG 9.5 %; TSI 4.8 % and EmA-Ig A 3.1 %. Children with thyroid antibodies (anti-TPO1) were significantly older and developed diabetes later in life (P < 0.05) than those without antibodies. Thyroid-stimulating hormone levels, goiter and thyroid dysfunction were higher in children who were anti-TPO1 than in diabetic children without thyroid autoimmunity.
Conclusions:
Children with newly diagnosed type 1 diabetes show a high prevalence of thyroid and coeliac autoimmunity. In cases of positivity, additional work-up and intervention are advocated. These measures can prevent the well-known complications of diabetes and improve its clinical course.
More Related Videos
Related Concept Videos
Type I Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes I: Introduction

